Clinical & Translational Research Unit (CTRU) & Spectrum BioBank, Stanford University is a clinical research site located in Palo Alto, California, United States 94304.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Clinical & Translational Research Unit (CTRU) & Spectrum BioBank, Stanford University has participated in 1 clinical trials.
Therapeutic areas: SARS-CoV-2 Infection, COVID-19.
Sponsors: BioNTech SE.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Clinical & Translational Research Unit (CTRU) & Spectrum BioBank, Stanford University has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Clinical & Translational Research Unit (CTRU) & Spectrum BioBank, Stanford University has 1 clinical trials on record. Their work covers SARS-CoV-2 Infection, COVID-19.
Clinical & Translational Research Unit (CTRU) & Spectrum BioBank, Stanford University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.